Document is current
Any future updates will be listed below
-
Authors
Rocha, Agostinho G.
Yu, Tony
Loveland, Magdalena
Patel, Dhrumi
Rodgers, Buel D. https://orcid.org/0000-0003-0751-1105
- License Information
-
More Information
Article History
Received: 19 June 2025
Accepted: 11 September 2025
First Online: 24 September 2025
Declarations
:
: B.D.R. is the CEO of Aavogen, Inc., which is developing AVGN7.2 for treating muscle wasting conditions. The other authors performed this research as a condition of Smithers Pharmaceutical Development Services.
